Betensky RA - Search Results

1

Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.

Plotkin SR, Betensky RA, Hochberg FH, Grossman SA, Lesser GJ, Nabors LB, Chon B, Batchelor TT. Plotkin SR, et al. Among authors: betensky ra. Clin Cancer Res. 2004 Sep 1;10(17):5643-6. doi: 10.1158/1078-0432.CCR-04-0159. Clin Cancer Res. 2004. PMID: 15355887

2

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN. Ino Y, et al. Among authors: betensky ra. Clin Cancer Res. 2001 Apr;7(4):839-45. Clin Cancer Res. 2001. PMID: 11309331

3

BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.

Braaten KM, Betensky RA, de Leval L, Okada Y, Hochberg FH, Louis DN, Harris NL, Batchelor TT. Braaten KM, et al. Among authors: betensky ra. Clin Cancer Res. 2003 Mar;9(3):1063-9. Clin Cancer Res. 2003. PMID: 12631608

4

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN. Nutt CL, et al. Among authors: betensky ra. Cancer Res. 2003 Apr 1;63(7):1602-7. Cancer Res. 2003. PMID: 12670911

5

Neurolymphomatosis.

Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH. Baehring JM, et al. Among authors: betensky ra. Neuro Oncol. 2003 Apr;5(2):104-15. doi: 10.1093/neuonc/nop021. Neuro Oncol. 2003. PMID: 12672282 Free PMC article.

6

Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment.

Baehring JM, Betensky RA, Batchelor TT. Baehring JM, et al. Among authors: betensky ra. Neurology. 2003 Sep 9;61(5):696-8. doi: 10.1212/01.wnl.0000078813.05925.2c. Neurology. 2003. PMID: 12963767

7

Age-dependent prognostic effects of genetic alterations in glioblastoma.

Batchelor TT, Betensky RA, Esposito JM, Pham LD, Dorfman MV, Piscatelli N, Jhung S, Rhee D, Louis DN. Batchelor TT, et al. Among authors: betensky ra. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):228-33. doi: 10.1158/1078-0432.ccr-0841-3. Clin Cancer Res. 2004. PMID: 14734474

8

YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.

Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimov AO. Nutt CL, et al. Among authors: betensky ra. Clin Cancer Res. 2005 Mar 15;11(6):2258-64. doi: 10.1158/1078-0432.CCR-04-1601. Clin Cancer Res. 2005. PMID: 15788675

9

Statistical considerations for immunohistochemistry panel development after gene expression profiling of human cancers.

Betensky RA, Nutt CL, Batchelor TT, Louis DN. Betensky RA, et al. J Mol Diagn. 2005 May;7(2):276-82. doi: 10.1016/S1525-1578(10)60555-7. J Mol Diagn. 2005. PMID: 15858152 Free PMC article.

10

Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma.

Baehring JM, Androudi S, Longtine JJ, Betensky RA, Sklar J, Foster CS, Hochberg FH. Baehring JM, et al. Among authors: betensky ra. Cancer. 2005 Aug 1;104(3):591-7. doi: 10.1002/cncr.21191. Cancer. 2005. PMID: 15973665 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters